Measuring treatment response to advance precision medicine for multiple sclerosis

OBJECTIVE: To assess the independent contributions of clinical measures (relapses, Expanded Disability Status Scale [EDSS] scores, and neuroperformance measures) and nonclinical measures (new brain magnetic resonance imaging [MRI] activity and serum neurofilament light chain [sNfL] levels) for disti...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabresi, Peter A., Kappos, Ludwig, Giovannoni, Gavin, Plavina, Tatiana, Koulinska, Irene, Edwards, Michael R., Kieseier, Bernd, de Moor, Carl, Sotirchos, Elias S., Fisher, Elizabeth, Rudick, Richard A., Sandrock, Alfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607451/
https://www.ncbi.nlm.nih.gov/pubmed/34704393
http://dx.doi.org/10.1002/acn3.51471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607451/
https://www.ncbi.nlm.nih.gov/pubmed/34704393
http://dx.doi.org/10.1002/acn3.51471

Ejemplares similares